Kavita Patel is a BoneFit™-trained physical therapist and passionate advocate for bone health. As a trainer, educator, and founder of a concierge wellness practice, she empowers individuals and communities with evidence-based strategies to stay active, strong, and fracture-free.
Join the Bone Buddies Online Virtual Support Group this July! Weekly sessions cover topics ranging from diet, exercise, treatment, and more!
The Bone Health & Osteoporosis Foundation (BHOF) is excited to introduce our new online fundraising platform, Fundraise Your Own Way! It’s an easy, flexible tool that helps you to create a personal page, share your story, and rally others to join you. Whether you want to celebrate a birthday or milestone, honor a loved one, host your own awareness-raising event, or turn your passion into a fundraiser, this platform truly gives you the tools to fundraise your own way.
Join the Bone Buddies Online Virtual Support Group this June! Weekly sessions cover topics ranging from diet, exercise, treatment, and more!
The National Osteoporosis Foundation has joined a group of 80+ organizations that have signed an Open Letter to lawmakers and committed to work with HHS, Congress and states on commonsense health reforms centered on patients and people with disabilities, while tackling affordability and nondiscrimination.
Drs. Adi Cohen and Elizabeth Shane are conducting a two-year treatment study for premenopausal women with idiopathic (unexplained) osteoporosis. This study will evaluate the efficacy of treatment with one year of romosozumab followed by one year of denosumab in premenopausal women with idiopathic osteoporosis. This an open-label study and not a randomized trial; all participants will receive both active treatments.
Dr. Adi Cohen is conducting a research study for women with pregnancy and lactation associated osteoporosis (PLO). This study aims to define the bone defect that leads to PLO and to better understand the causes, risk factors, predictors of disease severity, and natural history of PLO so that we can develop targeted treatment approaches. This study has been approved by the Columbia University Irving Medical Center IRB: #AAAR0960.
